Trial · NCT01811459
Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium
NCT01811459, Phase 3, Completed, Centre hospitalier de l'Université de Montréal (CHUM)
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium. Trials, record NCT01811459. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01811459
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium
- NCT number
- NCT01811459
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 107 participants, actual
- Lead sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Conditions
- Delirium
- Interventions
- Quetiapine, Haloperidol, Placebo
- First posted
- 2013-03-14
- Last updated
- 2018-02-09
Source ClinicalTrials.gov
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to first resolution of delirium | 21 days | Confirmed by clinical evaluation of a psychiatrist |
| Secondary | Days in delirium during the study | 21 days | From log |
| Secondary | Duration of delirium | 21 days | From log |
| Secondary | Severity of delirium (highest Nu-DESC score, mean episode Nu-DESC score) | 21 days | Nursing evaluation every 8 hours- shift |
| Secondary | ICU and hospital mortality | 21 days | From the chart |
| Secondary | ICU and hospital length of stay | 21 days | From the chart |
| Secondary | Length of mechanical ventilation | 21 days | From daily clinical évaluation |
| Secondary | Time spent deeply sedated (RASS <3) | 21 days | From chart |
| Secondary | Episodes of subject-initiated device removal | 21 days | From daily clinical évaluation |
| Secondary | Use of haloperidol therapy (including total dose in haloperidol equivalents during the study, number of doses, number of days of therapy, use of rescue IV haloperidol) | 21 days | From long |
1 to 10 of 17Source ClinicalTrials.gov
See all 17 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01811459
GET https://conductscience.org/api/trials/v1/NCT01811459/registered